Nano-X Imaging (NNOX) to Release Earnings on Thursday

Nano-X Imaging (NASDAQ:NNOX - Get Free Report) is anticipated to post its Q1 2025 quarterly earnings results before the market opens on Thursday, May 22nd. Analysts expect Nano-X Imaging to post earnings of ($0.23) per share and revenue of $3.98 million for the quarter.

Nano-X Imaging (NASDAQ:NNOX - Get Free Report) last announced its quarterly earnings results on Monday, March 31st. The company reported ($0.23) earnings per share for the quarter, missing analysts' consensus estimates of ($0.15) by ($0.08). Nano-X Imaging had a negative net margin of 465.38% and a negative return on equity of 27.63%. The firm had revenue of $3.00 million during the quarter, compared to analysts' expectations of $3.80 million. On average, analysts expect Nano-X Imaging to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Nano-X Imaging Trading Up 0.2%

Shares of NNOX stock traded up $0.01 during mid-day trading on Tuesday, reaching $5.49. The stock had a trading volume of 620,687 shares, compared to its average volume of 1,735,027. Nano-X Imaging has a 12-month low of $3.75 and a 12-month high of $11.00. The company has a market cap of $317.21 million, a P/E ratio of -6.46 and a beta of 2.03. The business has a 50-day simple moving average of $5.14 and a 200 day simple moving average of $6.35.

Analyst Ratings Changes

A number of research analysts have recently weighed in on the company. D. Boral Capital restated a "buy" rating and issued a $15.00 price target on shares of Nano-X Imaging in a research report on Thursday, April 17th. Cantor Fitzgerald dropped their price target on Nano-X Imaging from $12.00 to $9.00 and set an "overweight" rating for the company in a research report on Tuesday, April 1st.

Institutional Trading of Nano-X Imaging

An institutional investor recently raised its position in Nano-X Imaging stock. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in shares of Nano-X Imaging Ltd. (NASDAQ:NNOX - Free Report) by 232.4% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,160,806 shares of the company's stock after purchasing an additional 1,510,806 shares during the quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC owned approximately 3.74% of Nano-X Imaging worth $10,793,000 as of its most recent filing with the Securities and Exchange Commission. 21.49% of the stock is owned by hedge funds and other institutional investors.

Nano-X Imaging Company Profile

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode.